Short Summary
Omnidya Tech Llp filed petitions seeking revocation of two Indian patents (IN 317629 and IN 373372) before the Delhi High Court. The court issued notice to the relevant respondents and directed them to file their replies within six weeks.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Omnidya Tech Llp vs Jayant Ratti & Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Asianet Star Communications Pvt Ltd.vsThe Registrar Of Trademarks & Anr.
This Delhi High Court judgment addresses a dispute over the alleged abandonment of a registered trademark due to non-renewal. The petitioner argued that the mandatory O-3 notice for renewal was improperly backdated and uploaded using an outdated form (RG-3), making it invalid. The court recognized serious inconsistencies in the Trademark Registry's process, directing senior officials and the concerned Examiner to appear in court with explanations and documentation regarding the improper uploading of notices. Crucially, the court granted interim relief, ensuring the trademark would not be treated as abandoned pending a full inquiry.
Pfizer IncvsTriveni Interchem Private Limited
The plaintiff alleges infringement of its Indian Patent No. 218291 related to Palbociclib, marketed under the brand name 'Palbace'. The court found a prima facie case of infringement but noted the timeline of alleged infringement was unclear.
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyvsMs Glowsun India Labs Private Limited
Bristol-Myers Squibb filed a suit seeking permanent injunction against Ms Glowsun India Labs for infringing its patent (IN 247381) related to the drug APIXABAN. The parties subsequently resolved their dispute amicably through mediation, leading to a final settlement.
Shree Vari Multiplast India Pvt. Ltd.vsNilkamal Plastics Limited
Shree Vari Multiplast India Pvt. Ltd. filed a suit against Nilkamal Plastics Limited alleging infringement of Design No.176931 related to plastic moulded chairs, seeking permanent injunction and declaration that the Cease and Desist Notice was unjustifiable. The plaintiff argued that the design was common use in the industry and liable for rectification due to lack of novelty. However, the court ultimately dismissed the suit as infructuous, noting that the registered design's protection period had expired.
Unilever PlcvsMukesh
The applicants filed an interim application seeking the extension and granting of ad-interim injunctions against the defendants. The court granted temporary injunctions restraining the defendants from manufacturing or selling goods in the FMCG industry using counterfeit marks, pirated artwork, or trade dress deceptively similar to the plaintiffs' registered trademarks (VIM) and prior used trademarks (U-Logo, SURF/SURF EXCEL).
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.